Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,514
datasets available to search
ShareScore release 0.9.0
Dataset results
3,514 results for “cell therapy”
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
ClinicalTrials.gov study NCT06071624. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma
ClinicalTrials.gov study NCT07244666. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer
ClinicalTrials.gov study NCT01194609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05701176. IPD Sharing: NO. Countries: 1. Publications: 0.
Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy
ClinicalTrials.gov study NCT07341191. IPD Sharing: YES. Countries: 0. Publications: 0.
Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07054086. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05800405. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Therapy for AML Minimal Residual Disease
ClinicalTrials.gov study NCT05601830. IPD Sharing: NO. Countries: 1. Publications: 0.
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT06343311. IPD Sharing: NO. Countries: 1. Publications: 0.
FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07221032. IPD Sharing: NO. Countries: 1. Publications: 0.
The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
ClinicalTrials.gov study NCT00751543. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19 and CD22 Targeted CAR-T Cell Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma
ClinicalTrials.gov study NCT04649983. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
ClinicalTrials.gov study NCT06357754. IPD Sharing: NO. Countries: 4. Publications: 0.
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
ClinicalTrials.gov study NCT01090466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL
ClinicalTrials.gov study NCT05554939. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06935136. IPD Sharing: NO. Countries: 1. Publications: 0.
Zanubrutinib-based Induction and Maintenance Therapy in Young and Fit Patients With Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04736914. IPD Sharing: NO. Countries: 1. Publications: 0.
4SCAR-CD44v6 T Cell Therapy Targeting Cancer
ClinicalTrials.gov study NCT04427449. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy
ClinicalTrials.gov study NCT06556355. IPD Sharing: YES. Countries: 1. Publications: 0.
Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia
ClinicalTrials.gov study NCT01020539. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.